Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GSK Sets Aside $3.4 Billion Over Avandia Liabilities: Biotech's Latest Tribulations
GSK Sets Aside $3.4 Billion Over Avandia Liabilities: Biotech's Latest Tribulations
GSK Sets Aside $3.4 Billion Over Avandia Liabilities: Biotech's Latest Tribulations
Submitted by
admin
on January 24, 2011 - 11:09am
Source:
Seeking Alpha
News Tags:
GAK
Avandia
diabetes
legal
Headline:
GSK Sets Aside $3.4 Billion Over Avandia Liabilities: Biotech's Latest Tribulations
Do Not Allow Advertisers to Use My Personal information
